• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Gilead Sciences (GILD)

Common Shares
Sell: $106.34|Buy: $106.79|Change: 3.17 (3.07%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Address

333 Lakeside Drive
Foster
CA
USA
94404

Telephone

+1 650 574-3000

Website

https://www.gilead.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Gilead Sciences Inc First Quarter Earnings Conference Call for 20262026-04-24T16:30:00
Gilead Sciences Inc First Quarter Earnings Results for 20262026-04-24T00:00:00
Gilead Sciences Inc Annual Report for 20252026-02-27T00:00:00
Gilead Sciences Inc Fourth Quarter Earnings Conference Call for 20252026-02-11T16:30:00
Gilead Sciences Inc Fourth Quarter Earnings Results for 20252026-02-11T00:00:00
Gilead Sciences Inc Third Quarter Earnings Conference Call for 20252025-11-06T16:30:00
Gilead Sciences Inc Third Quarter Earnings Results for 20252025-11-06T00:00:00
Gilead Sciences Inc Second Quarter Earnings Conference Call for 20252025-08-08T16:30:00
Gilead Sciences Inc Second Quarter Earnings Results for 20252025-08-08T00:00:00
Gilead Sciences Inc Annual General Meeting for 20252025-05-07T10:00:00
Gilead Sciences Inc First Quarter Earnings Conference Call for 20252025-04-24T16:30:00
Gilead Sciences Inc First Quarter Earnings Result for 20252025-04-24T00:00:00

Previous key dates

NameKey Date
Gilead Sciences Inc First Quarter Earnings Conference Call for 20252025-04-24T16:30:00
Gilead Sciences Inc First Quarter Earnings Result for 20252025-04-24T00:00:00
Leerink Partners Global Healthcare Conference2025-03-11T10:40:00
TD Cowen Annual Health Care Conference2025-03-04T11:40:00
Gilead Sciences Inc Annual Report for 20242025-02-28T00:00:00
Gilead Sciences Inc Fourth Quarter Earnings Conference Call for 20242025-02-11T16:30:00
Gilead Sciences Inc Fourth Quarter Earnings Result for 20242025-02-11T00:00:00
J.P. Morgan Healthcare Conference2025-01-13T11:15:00
Gilead Sciences Inc Third Quarter Earnings Conference Call for 20242024-11-06T16:30:00
Gilead Sciences Inc Third Quarter Earnings Result for 20242024-11-06T00:00:00
Baird Global Healthcare Conference2024-09-10T10:50:00
Morgan Stanley Annual Global Healthcare Conference2024-09-05T12:20:00
Wells Fargo Healthcare Conference2024-09-04T11:00:00
Gilead Sciences Inc Second Quarter Earnings Conference Call for 20242024-08-08T16:30:00
Gilead Sciences Inc Second Quarter Earnings Result for 20242024-08-08T00:00:00
Goldman Sachs Annual Global Healthcare Conference2024-06-12T13:20:00
Jefferies Global Healthcare Conference2024-06-05T11:00:00
RBCCM Global Healthcare Conference2024-05-15T10:30:00
BofA Securities Health Care Conference2024-05-14T11:20:00
Gilead Sciences Inc Annual General Meeting for 20242024-05-08T10:00:00
Gilead Sciences Inc First Quarter Earnings Conference Call for 20242024-04-25T16:30:00
Gilead Sciences Inc First Quarter Earnings Result for 20242024-04-25T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.